News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
765,037 Results
Type
Article (46960)
Company Profile (343)
Press Release (717720)
Multimedia
Podcasts (139)
Webinars (21)
Section
Business (216878)
Career Advice (2279)
Deals (37664)
Drug Delivery (133)
Drug Development (85013)
Employer Resources (179)
FDA (17459)
Job Trends (15981)
News (367370)
Policy (35542)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2700)
Accelerated approval (33)
Adcomms (28)
Allergies (152)
Alliances (53355)
ALS (177)
Alzheimer's disease (1717)
Antibody-drug conjugate (ADC) (330)
Approvals (17698)
Artificial intelligence (554)
Autoimmune disease (161)
Automation (39)
Bankruptcy (378)
Best Places to Work (12054)
BIOSECURE Act (21)
Biosimilars (202)
Biotechnology (198)
Bladder cancer (159)
Brain cancer (60)
Breast cancer (654)
Cancer (4941)
Cardiovascular disease (420)
Career advice (1930)
Career pathing (38)
CAR-T (303)
CDC (51)
Celiac Disease (2)
Cell therapy (795)
Cervical cancer (36)
Clinical research (72379)
Collaboration (1805)
Company closure (4)
Compensation (1179)
Complete response letters (67)
COVID-19 (2864)
CRISPR (98)
C-suite (885)
Cystic fibrosis (149)
Data (6306)
Decentralized trials (2)
Denatured (43)
Depression (142)
Diabetes (524)
Diagnostics (6954)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (266)
Drug pricing (213)
Drug shortages (33)
Duchenne muscular dystrophy (241)
Earnings (94038)
Editorial (62)
Employer branding (21)
Employer resources (159)
Events (123979)
Executive appointments (1016)
FDA (20666)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1522)
Gene editing (208)
Generative AI (46)
Gene therapy (655)
GLP-1 (1064)
Government (4994)
Grass and pollen (8)
Guidances (386)
Healthcare (19585)
HIV (59)
Huntington's disease (46)
IgA nephropathy (85)
Immunology and inflammation (273)
Immuno-oncology (61)
Indications (111)
Infectious disease (3140)
Inflammatory bowel disease (196)
Inflation Reduction Act (14)
Influenza (120)
Intellectual property (255)
Interviews (359)
IPO (17268)
IRA (58)
Job creations (4282)
Job search strategy (1623)
JPM (67)
Kidney cancer (16)
Labor market (86)
Layoffs (603)
Leadership (34)
Legal (8777)
Liver cancer (95)
Longevity (15)
Lung cancer (660)
Lymphoma (380)
Machine learning (43)
Management (63)
Manufacturing (855)
MASH (170)
Medical device (14574)
Medtech (14629)
Mergers & acquisitions (21476)
Metabolic disorders (1354)
Multiple sclerosis (162)
NASH (17)
Neurodegenerative disease (334)
Neuropsychiatric disorders (93)
Neuroscience (2997)
Neurotech (1)
NextGen: Class of 2026 (6858)
Non-profit (4635)
Now hiring (67)
Obesity (649)
Opinion (303)
Ovarian cancer (168)
Pain (216)
Pancreatic cancer (232)
Parkinson's disease (290)
Partnered (34)
Patents (512)
Patient recruitment (498)
Peanut (59)
People (62329)
Pharmaceutical (98)
Pharmacy benefit managers (31)
Phase 1 (22518)
Phase 2 (31783)
Phase 3 (23819)
Pipeline (5370)
Policy (312)
Postmarket research (2713)
Preclinical (9563)
Press Release (72)
Prostate cancer (243)
Psychedelics (51)
Radiopharmaceuticals (294)
Rare diseases (891)
Real estate (6586)
Recruiting (73)
Regulatory (26407)
Reports (52)
Research institute (2500)
Resumes & cover letters (380)
Rett syndrome (28)
RNA editing (17)
RSV (80)
Schizophrenia (158)
Series A (255)
Series B (198)
Service/supplier (14)
Sickle cell disease (100)
Special edition (25)
Spinal muscular atrophy (164)
Sponsored (45)
Startups (3927)
State (2)
Stomach cancer (18)
Supply chain (109)
Tariffs (99)
The Weekly (94)
Vaccines (1088)
Venture capital (92)
Weight loss (433)
Women's health (93)
Worklife (19)
Date
Today (34)
Last 7 days (634)
Last 30 days (2164)
Last 365 days (30865)
2026 (3557)
2025 (31263)
2024 (36502)
2023 (41412)
2022 (52685)
2021 (57410)
2020 (56015)
2019 (48808)
2018 (36860)
2017 (34279)
2016 (33968)
2015 (39981)
2014 (33770)
2013 (28927)
2012 (31111)
2011 (31720)
2010 (29590)
Location
Africa (840)
Alabama (83)
Alaska (7)
Arizona (329)
Arkansas (14)
Asia (44314)
Australia (7162)
California (11500)
Canada (3332)
China (1165)
Colorado (489)
Connecticut (491)
Delaware (347)
Europe (96017)
Florida (1700)
Georgia (362)
Hawaii (4)
Idaho (64)
Illinois (908)
India (68)
Indiana (545)
Iowa (23)
Japan (444)
Kansas (131)
Kentucky (40)
Louisiana (27)
Maine (83)
Maryland (1417)
Massachusetts (8305)
Michigan (349)
Minnesota (648)
Mississippi (6)
Missouri (140)
Montana (34)
Nebraska (28)
Nevada (124)
New Hampshire (82)
New Jersey (3072)
New Mexico (30)
New York (3018)
North Carolina (1526)
North Dakota (10)
Northern California (5618)
Ohio (341)
Oklahoma (22)
Oregon (47)
Pennsylvania (2312)
Puerto Rico (24)
Rhode Island (48)
South America (1250)
South Carolina (67)
South Dakota (1)
Southern California (4457)
Tennessee (175)
Texas (1790)
United States (41029)
Utah (344)
Vermont (1)
Virginia (283)
Washington D.C. (82)
Washington State (949)
West Virginia (4)
Wisconsin (115)
Wyoming (2)
765,037 Results for "tap pharmaceutical products inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aucta Pharmaceuticals, Inc. (“Aucta Pharmaceuticals”) prepares for the launch of PYQUVI™ (deflazacort) oral suspension, the first of a new branded-generic rare disease product line
February 8, 2026
·
7 min read
Press Releases
Nanox Receives FDA 510(k) Clearance for TAP2D New Image Enhancement Capability for Nanox.ARC and Nanox.ARC X Systems
February 3, 2026
·
6 min read
Autoimmune disease
Sanofi Taps Dren Again in up to $1.7B Autoimmune Partnership
Sanofi bought Dren’s DR-0201 program earlier this year for $600 million upfront and is running two Phase I trials in undisclosed inflammatory indications.
December 15, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
BiVACOR Total Artificial Heart Accepted into FDA’s Total Product Life Cycle (TAP) Program
August 7, 2025
·
4 min read
Recruiting
Facing Talent Crunch, Radiopharma Field Casts a Wide Net
As the field grows rapidly, companies are luring people from other nuclear industries and tapping the expanding educational talent pipeline, but are constrained by a steep learning curve and the value of real-world experience.
February 10, 2026
·
4 min read
·
Nick Paul Taylor
Press Releases
Convatec awarded Enterostomal Therapy Products agreements with Premier, Inc.
February 10, 2026
·
2 min read
Press Releases
Utah Medical Products, Inc. Announces Quarterly Dividend - February 4, 2026
February 5, 2026
·
1 min read
Press Releases
Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate
February 2, 2026
·
3 min read
Press Releases
Kodak Expands Pharmaceuticals Portfolio with Four Regulated Products
January 27, 2026
·
2 min read
Press Releases
Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity
October 9, 2025
·
6 min read
1 of 76,504
Next
